Lyon Joseph Douglas
See Remarks | Chief Accounting Officer
1 company
Insider Signal Score
50
AverageTrades Analyzed
35
12M Win Rate
33.3%
Avg 3M Return
-3.5%
Avg 12M Return
-38.0%
Lyon Joseph Douglas is a See Remarks at CORCEPT THERAPEUTICS INC. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $497K based on current market prices.
Holdings by Company
CORTMay 27, 2026
Current Shares6.2K
Value$496.6K
Net Activity-461,411
Bought: 0Sold: 461.4K
Transaction History
Showing 10 filings (page 2)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2025 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 200,650 | $100.51 | $20,167,953.55 | -71.7% | -20.2% | -54.3% | |
| Mar 24, 2025 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 421 | $60.58 | $25,504.18 | -4.5% | +24.9% | -43.1% | |
| Mar 3, 2025 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 4,579 | $60.69 | $277,901.80 | -33.7% | +21.3% | -40.3% | |
| Feb 3, 2025 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 5,000 | $66.92 | $334,600.00 | -36.3% | +11.1% | -38.8% | |
| Jan 2, 2025 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 5,000 | $50.39 | $251,950.00 | -36.3% | +67.7% | -23.6% | |
| Nov 22, 2024 | CORT Corcept Therapeutics Inc | See Remarks | Sell | 1,411 | $56.72 | $80,031.92 | -14.2% | +13.1% | +34.3% | |
| Jul 1, 2024 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 5,000 | $32.49 | $162,452.00 | -35.0% | +41.7% | +112.2% | |
| Jun 3, 2024 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 5,000 | $30.18 | $150,916.00 | -40.6% | +9.5% | +122.1% | |
| May 9, 2024 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 7,227 | $26.00 | $187,902.00 | -49.7% | +28.0% | +164.0% | |
| May 2, 2024 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 10,830 | $26.00 | $281,580.00 | -59.7% | +54.3% | +190.4% |